Residual and Recurrent Gastrointestinal Stromal Tumors With KIT Mutations: Findings at First Follow-Up CT After Imatinib Treatment

被引：3
|
作者：
Choi, Dongil [1 ,2 ]
Yoo, Eun Young [1 ,2 ]
Kim, Kyoung-Mee [3 ]
Sohn, Tae Sung [4 ]
Lee, Won Jae [1 ,2 ]
Lee, Ji Young [1 ,2 ]
Chang, Ilsoo [1 ,2 ]
机构：
[1] Sungkyunkwan Univ, Sch Med, Dept Radiol, Kangnam Ku, Seoul 135710, South Korea
[2] Sungkyunkwan Univ, Sch Med, Ctr Imaging Sci, Kangnam Ku, Seoul 135710, South Korea
[3] Sungkyunkwan Univ, Sch Med, Dept Pathol, Samsung Med Ctr, Seoul, South Korea
[4] Sungkyunkwan Univ, Sch Med, Dept Surg, Samsung Med Ctr, Seoul, South Korea
来源：
AMERICAN JOURNAL OF ROENTGENOLOGY | 2009年 / 193卷 / 02期
关键词：
cystic change; follow-up CT; gastrointestinal stromal tumor; GIST; imatinib treatment; KIT mutation; POSITRON-EMISSION-TOMOGRAPHY; TYROSINE KINASE; POOR-PROGNOSIS; CYSTIC CHANGES; MESYLATE; INHIBITION; METASTASES; RESISTANCE; DELETIONS; BIOLOGY;
D O I：
10.2214/AJR.08.2106
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OBJECTIVE. The purpose of this study was to correlate findings on the first follow-up CT after treatment with imatinib in patients with residual or recurrent gastrointestinal stromal tumors (GISTs) with the different types of KIT mutation present at initial resection. CONCLUSION. Residual and recurrent GISTs with KIT mutation of exon 11 deletion more frequently showed both tumor shrinkage and cystic change on 2-month follow-up CT images after the start of imatinib treatment than did other mutation types.
引用
收藏
页码：W100 / W105
页数：6
相关论文
共 50 条
  • [1] KIT and BRAF heterogeneous mutations in gastrointestinal stromal tumors after secondary imatinib resistance
    Zheng, Song
    Huang, Ke-er
    Pan, Yue-long
    Zhou, Yao
    Pan, Song-dan
    Li, Xin
    Jia, Jing
    Zheng, Xiao-liang
    Tao, De-you
    GASTRIC CANCER, 2015, 18 (04) : 796 - 802
  • [2] Long-Term Follow-Up Outcome of Imatinib Mesylate Treatment for Recurrent and Unresectable Gastrointestinal Stromal Tumors
    Saito, Seiko
    Nakata, Katsunori
    Kajiura, Shinya
    Ando, Takamaso
    Hosokawa, Ayumu
    Sugiyama, Toshiro
    DIGESTION, 2013, 87 (01) : 47 - 52
  • [3] KIT and BRAF heterogeneous mutations in gastrointestinal stromal tumors after secondary imatinib resistance
    Song Zheng
    Ke-er Huang
    Yue-long Pan
    Yao Zhou
    Song-dan Pan
    Xin Li
    Jing Jia
    Xiao-liang Zheng
    De-you Tao
    Gastric Cancer, 2015, 18 : 796 - 802
  • [4] Imatinib therapy after resection of high-risk gastrointestinal stromal tumors in Chinese patients: a median follow-up of 48 months
    Lei, Cheng
    Zhao, Bing
    Wang, Qisan
    Ge, Lei
    Wang, Haijiang
    JOURNAL OF BUON, 2018, 23 (02): : 460 - 467
  • [5] Follow-up strategies for patients with gastrointestinal stromal tumour treated with or without adjuvant imatinib after surgery
    Joensuu, H.
    Martin-Broto, J.
    Nishida, T.
    Reichardt, P.
    Schoffski, P.
    Maki, R. G.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 (12) : 1611 - 1617
  • [6] KIT mutations and imatinib dose effects in patients with gastrointestinal stromal tumors -: Reply
    Heinrich, Michael C.
    Corless, Christopher L.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (09) : 1147 - 1148
  • [7] The standard diagnosis, treatment, and follow-up of gastrointestinal stromal tumors based on guidelines
    Nishida, Toshirou
    Blay, Jean-Yves
    Hirota, Seiichi
    Kitagawa, Yuko
    Kang, Yoon-Koo
    GASTRIC CANCER, 2016, 19 (01) : 3 - 14
  • [8] Complete remission of recurrent gastrointestinal stromal tumors after treatment with imatinib: Report of a case
    Kobayashi, Michiya
    Okamoto, Ken
    Nakatani, Hajime
    Okabayashi, Takehiro
    Namikawa, Tsutomu
    Ichikawa, Kengo
    Kitagawa, Hiroyuki
    Araki, Keijiro
    SURGERY TODAY, 2006, 36 (08) : 727 - 732
  • [9] Fourteen-year follow-up results of imatinib therapy in patients with unresectable and metastatic gastrointestinal stromal tumors
    Kanda, Tatsuo
    Ichikawa, Hiroshi
    Ishikawa, Takashi
    Muneoka, Yusuke
    Kano, Yosuke
    Naito, Tetsuya
    Suzuki, Satoshi
    Wakai, Toshifumi
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2024, 29 (12) : 1870 - 1877
  • [10] Complete Remission of Recurrent Gastrointestinal Stromal Tumors After Treatment with Imatinib: Report of a Case
    Michiya Kobayashi
    Ken Okamoto
    Hajime Nakatani
    Takehiro Okabayashi
    Tsutomu Namikawa
    Kengo Ichikawa
    Hiroyuki Kitagawa
    Keijiro Araki
    Surgery Today, 2006, 36 : 727 - 732
12345